Laboratory Nexus is pleased to present a turnkey clinical laboratory opportunity located in Pennsylvania. This approximately 3,000 square foot laboratory has been built out to support both toxicology and molecular (PCR) testing and is available through an outright acquisition.

The laboratory recently completed its Pennsylvania Department of Health inspection and is operating under an active CLIA Certificate of Registration.

The ownership group has other business interests and is seeking an outright sale of the laboratory assets while remaining available to assist during the transition. This represents an excellent opportunity for a buyer looking to enter the clinical laboratory industry without the time, cost, and complexity of building a laboratory from the ground up.

Laboratory Highlights:

Approximately 3,000 square feet
Turnkey clinical laboratory
Built out for Toxicology and Molecular (PCR)
Pennsylvania licensed laboratory
Active CLIA Certificate of Registration
Owners willing to provide transition support
No outstanding debt

Instrumentation:

Molecular
(2) Bio-Rad CFX Opus 384 Real-Time PCR Systems

Toxicology
Agilent LC-MS/MS toxicology platform
(Additional equipment list available upon request.)

Opportunity
This offering provides an exceptional opportunity to acquire an operational laboratory designed for both toxicology and molecular diagnostics. Buyers can significantly reduce the time and capital typically required for permitting, construction, validation, and laboratory buildout.

Whether expanding an existing laboratory network or entering the diagnostics industry, this facility provides a strong foundation with modern infrastructure and room for future growth.